Shares of HealthEquity, the nation's largest health savings account (HSA) custodian, plunged 9.38% in Tuesday's intraday trading session. The sell-off was primarily driven by the company's fiscal 2026 revenue outlook, which fell short of analyst expectations.
For the fiscal year ending January 31, 2026, HealthEquity forecasted revenue between $1.275 billion and $1.295 billion, trailing the average analyst estimate of $1.32 billion. The company cited an expected slowdown in growth for its HSA business as the primary reason for the lower-than-expected revenue guidance.
Despite the disappointing outlook for fiscal 2026, HealthEquity reported better-than-expected earnings and revenue for the fiscal third quarter of 2025 ended October 31, 2024. The company posted non-GAAP earnings of $0.78 per share, beating the consensus estimate of $0.72, and revenue rose 20.6% year-over-year to $300.4 million, slightly ahead of analyst expectations of $305.3 million.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。